Common Contracts
2 similar Asset Purchase Agreement contracts by Opko Health, Inc.
ASSET PURCHASE AGREEMENT dated as of March 27, 2024 by and among BIOREFERENCE HEALTH, LLC, OPKO HEALTH, INC. and LABORATORY CORPORATION OF AMERICA HOLDINGSAsset Purchase Agreement • March 28th, 2024 • Opko Health, Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of March 27, 2024 (the “Agreement Date”), by and among BioReference Health, LLC, a Delaware limited liability company (“Seller”), Laboratory Corporation of America Holdings, a Delaware corporation (“Buyer”), and OPKO Health, Inc., a Delaware corporation (“Seller Parent”, and together with Seller the “Seller Parties”). Capitalized terms not otherwise defined in this Agreement are defined in Exhibit A.
ASSET PURCHASE AGREEMENT dated as of March 27, 2024 by and among BIOREFERENCE HEALTH, LLC, OPKO HEALTH, INC. and LABORATORY CORPORATION OF AMERICA HOLDINGSAsset Purchase Agreement • March 28th, 2024 • Opko Health, Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of March 27, 2024 (the “Agreement Date”), by and among BioReference Health, LLC, a Delaware limited liability company (“Seller”), Laboratory Corporation of America Holdings, a Delaware corporation (“Buyer”), and OPKO Health, Inc., a Delaware corporation (“Seller Parent”, and together with Seller the “Seller Parties”). Capitalized terms not otherwise defined in this Agreement are defined in Exhibit A.
